Mise au point : Grossesse et risque thromboembolique veineux.

Titre original : 
VTE risk assessment in pregnancy.
Titre en français : 
Mise au point Grossesse et risque thromboembolique veineux.
Auteurs : 
Karl Ewins, Fionnuala Ní Ainle
Revue : 
Res Pract Thromb Haemost. 2020 Feb; 4(2): 183–192.

Résumé : 

A State of the Art lecture, "VTE Risk Assessment in Pregnancy," was presented at the ISTH congress in Melbourne, Australia, in 2019. Venous thromboembolism (VTE) remains a leading cause of death in pregnancy and in the postpartum period. Moreover, VTE can result in lifelong disability. The elevated baseline pregnancy-associated VTE risk is further increased by additional maternal, pregnancy, and delivery characteristics, highlighting the importance of VTE risk assessment in early pregnancy, at delivery, and if risk factors change. This review will provide an overview of the impact and epidemiology of VTE in pregnancy (including reported risk factors for pregnancy-associated VTE), will address VTE risk-reduction strategies (including ongoing studies), and will provide a summary of critical knowledge gaps. Finally, throughout this review, relevant new data presented during the 2019 ISTH annual congress in Melbourne will be summarized.